Macular Hole Surgery | Pristyn Care

Risk Factors

Risk factors for macular hole formation and poor surgical outcomes:

• Age over 60 years – most macular holes occur in this age group
• Female sex – women are more commonly affected than men
• High myopia increasing the risk of myopic macular hole development
• Large hole size (over 400 microns) associated with lower closure rates
• Long duration of symptoms before surgery reducing post-operative visual recovery

Candidacy

Surgery is recommended for all stages 2 to 4 macular holes due to the low rate of spontaneous closure and the high success rate of surgical repair. Stage 1 holes may be observed for spontaneous resolution for up to 3 months. Early surgery before significant visual loss has occurred is associated with better post-operative vision outcomes. Patients should be prepared for the 1 to 2 week face-down posturing requirement.

Diagnosis

Diagnostic evaluation for macular hole includes:

• Optical coherence tomography (OCT) – gold standard for macular hole staging and measurement
• Best corrected visual acuity testing for functional assessment
• Amsler grid testing to assess the degree of central visual distortion
• Dilated fundus examination to visualize the hole and assess the vitreous
• OCT angiography to evaluate macular vascularity in complex cases

Treatment Options

Macular hole surgery (vitrectomy with ILM peeling and gas tamponade) is the only effective treatment for full-thickness macular holes. No pharmacological or laser treatment reliably closes a macular hole. Ocriplasmin (enzymatic vitreolysis) may be used for selected small holes with vitreomacular traction but has limited efficacy for established full-thickness defects.

Macular Hole Surgery Steps

Macular hole surgery at Pristyn Care involves the following steps:

• Retrobulbar anesthesia with IV sedation to ensure a comfortable and still surgical field
• Pars plana vitrectomy performed to remove the vitreous gel and release all traction
• Indocyanine green (ICG) or brilliant blue dye used to stain the internal limiting membrane
• ILM peeled from a 2 to 3 disc-diameter area around the macular hole under high magnification
• Any residual epiretinal or tractional tissue removed to eliminate all traction forces
• Long-acting intraocular gas (C3F8 or SF6) injected as tamponade to support hole closure
• Eye wounds closed with sutures or left sutureless depending on instrument gauge used
• Strict face-down posturing required for 1 to 2 weeks after the procedure

Recovery After Surgery

Recovery after macular hole surgery involves:

• Face-down posturing maintained for 1 to 2 weeks for optimal gas tamponade positioning
• Using prescribed antibiotic and steroid eye drops for 4 to 6 weeks post-surgery
• Avoiding air travel until the intraocular gas has completely absorbed
• Visual improvement begins as the gas absorbs, typically over 6 to 12 weeks
• Final visual recovery continues over 3 to 12 months depending on hole size and duration
• Follow-up OCT scans performed to confirm macular hole closure and monitor recovery

Risks and Complications of Macular Hole Surgery

Potential complications of macular hole surgery include:

• Hole closure failure – occurs in 5 to 10 percent of cases, requiring repeat surgery
• Cataract formation in the operated eye, typically within 1 to 2 years after vitrectomy
• Retinal tear or retinal detachment as a surgical complication
• Post-operative infection (endophthalmitis) – rare but requires urgent treatment
• Elevated intraocular pressure from gas tamponade requiring eye drop management
• Persistence of visual distortion despite anatomical hole closure
• Macular hole reopening in a small percentage of patients months after repair
• Subretinal fluid or retinal changes noted on post-operative OCT imaging